Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
19.21
-0.74 (-3.71%)
At close: Jul 10, 2026, 4:00 PM EDT
19.63
+0.42 (2.17%)
After-hours: Jul 10, 2026, 6:05 PM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $1.01 billion as of July 10, 2026. Its market cap has increased by 1,845.64% in one year.
Market Cap
1.01B
Enterprise Value
928.12M
1-Year Change
1,845.64%
Ranking
Category
Stock Price
$19.21
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $1.01B, an increase of 2,826.91%. That is a compound annual growth rate of 37.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.01B | 206.65% |
| Dec 31, 2025 | 329.30M | 326.55% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
| Nov 13, 2015 | 34.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Solid Biosciences | 1.09B |
| Olema Pharmaceuticals | 1.08B |
| Kura Oncology | 1.07B |
| Arbutus Biopharma | 1.04B |
| Janux Therapeutics | 1.03B |
| Inventiva | 1.01B |
| Pharming Group | 1.01B |
| Geron | 1.01B |